Laura Sanchez-Izquierdo

San Sebastian, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Colorectal Cancer Mortality Following an Organized Fecal Immunochemical Test-Based Screening Program.

Colorectal Cancer Mortality Following an Organized Fecal Immunochemical Test-Based Screening Program.

Journal: JAMA network open

Published: August 05, 2026

Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

Journal: Journal of hepatology

Published: February 06, 2026

Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.

Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.

Journal: JHEP reports : innovation in hepatology

Published: November 11, 2025

Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis.

Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis.

Journal: Biomarker research

Published: September 03, 2025

Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC.

Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 18, 2025

Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.

Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.

Journal: Hepatology (Baltimore, Md.)

Published: July 15, 2025

Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.

Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.

Journal: Hepatology (Baltimore, Md.)

Published: July 15, 2025

Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis.

Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis.

Journal: JHEP reports : innovation in hepatology

Published: July 01, 2025

E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p.

E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p.

Journal: Hepatology (Baltimore, Md.)

Published: January 30, 2025

Genome-wide DNA methylation markers associated with metabolic liver cancer.

Genome-wide DNA methylation markers associated with metabolic liver cancer.

Journal: medRxiv : the preprint server for health sciences

Published: November 28, 2024

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement.

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement.

Journal: Hepatology (Baltimore, Md.)

Published: November 18, 2024

Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer.

Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer.

Journal: Gastro hep advances

Published: October 24, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026